Playback speed
10 seconds
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Lance Sloan
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Lance Sloan
8,643 views
June 17, 2019
Comments 3
Login to view comments.
Click here to Login
Recommended
AUTOPLAY